137 related articles for article (PubMed ID: 15319805)
1. Pupillometry in the detection of concomitant drug use in opioid-maintained patients.
Murillo R; Crucilla C; Schmittner J; Hotchkiss E; Pickworth WB
Methods Find Exp Clin Pharmacol; 2004 May; 26(4):271-5. PubMed ID: 15319805
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
Lintzeris N; Mitchell TB; Bond AJ; Nestor L; Strang J
Drug Alcohol Depend; 2007 Dec; 91(2-3):187-94. PubMed ID: 17624687
[TBL] [Abstract][Full Text] [Related]
3. Opioid dependence: rationale for and efficacy of existing and new treatments.
Fiellin DA; Friedland GH; Gourevitch MN
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
5. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
6. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
[TBL] [Abstract][Full Text] [Related]
7. Program monitoring for clinical practice. Specimen positivity across urine collection methods.
Moran J; Mayberry C; Kinniburgh D; James D
J Subst Abuse Treat; 1995; 12(3):223-6. PubMed ID: 7474030
[TBL] [Abstract][Full Text] [Related]
8. Measurement of pupil reactivity using fast pupillometry.
Hachol A; Szczepanowska-Nowak W; Kasprzak H; Zawojska I; Dudzinski A; Kinasz R; Wygledowska-Promienska D
Physiol Meas; 2007 Jan; 28(1):61-72. PubMed ID: 17151420
[TBL] [Abstract][Full Text] [Related]
9. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program.
Levy S; Vaughan BL; Angulo M; Knight JR
J Adolesc Health; 2007 May; 40(5):477-82. PubMed ID: 17448411
[TBL] [Abstract][Full Text] [Related]
11. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
[TBL] [Abstract][Full Text] [Related]
12. [Central nervous system activation in opioid dependent patients, evaluation with Fourier analysis of pupillary oscillations].
Grünberger J; Linzmayer L; Fischer G; Pezawas L; Stöhr H; Grünberger M
Wien Klin Wochenschr; 2000 Jan; 112(2):75-9. PubMed ID: 10703155
[TBL] [Abstract][Full Text] [Related]
13. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a polyethylene glycol marker system in urine drug screening in an opiate substitution program.
Schneider HJ; Rühl B; Meyer K; Keller R; Backmund M
Eur Addict Res; 2008; 14(4):186-9. PubMed ID: 18583915
[TBL] [Abstract][Full Text] [Related]
15. [Pupillary diameter and pupillary reactions in heroin dependent patients and in patients participating in a methadone and morphine replacement program].
Linzmayer L; Fischer G; Grünberger J
Wien Med Wochenschr; 1997; 147(3):67-9. PubMed ID: 9173676
[TBL] [Abstract][Full Text] [Related]
16. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
[TBL] [Abstract][Full Text] [Related]
17. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
18. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
19. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
20. Operational implications of varying ambient light levels and time-of-day effects on saccadic velocity and pupillary light reflex.
Yu M; Kautz MA; Thomas ML; Johnson D; Hotchkiss ER; Russo MB
Ophthalmic Physiol Opt; 2007 Mar; 27(2):130-41. PubMed ID: 17324202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
